Analyze Diet
American journal of veterinary research2005; 66(6); 1032-1038; doi: 10.2460/ajvr.2005.66.1032

Effects of oral administration of levothyroxine sodium on concentrations of plasma lipids, concentration and composition of very-low-density lipoproteins, and glucose dynamics in healthy adult mares.

Abstract: To evaluate glucose and lipid metabolism in healthy adult horses administered levothyroxine sodium (L-T4). Methods: 12 healthy adult mares. Methods: 8 horses received an incrementally increasing dosage of L-T4 (24, 48, 72, or 96 mg of L-T4/d) for weeks 1 to 8. Each dose was provide between 7 AM and 8 AM in the morning grain meal for 2 weeks. Four additional horses remained untreated. Serum concentrations of nonesterified fatty acids, triglyceride (TG), total cholesterol (TC), and very-low-density lipoprotein (VLDL) were measured and composition of VLDL examined in samples obtained between 8 AM and 9 AM at weeks 0, 2, 4, 6, and 8. Glucose dynamics were assessed by use of a combined IV glucose-insulin tolerance test (IVGITT) conducted before and at the end of the 8-week treatment period. Data for each combined IVGITT were interpreted by use of the minimal model. Results: Plasma TG, TC, and VLDL concentrations significantly decreased over time in treated horses. At the completion of the 8-week treatment period, mean plasma VLDL concentration was 46% of the mean value for week 0 in treated horses. Insulin sensitivity significantly increased (> 2-fold) in treated horses, but glucose effectiveness and net insulin response were not affected. Levothyroxine sodium significantly increased the rate of insulin disposal. Conclusions: Administration of L-T4 decreases blood lipid concentrations, improves insulin sensitivity, and increases insulin disposal in horses. Levothyroxine sodium may have potential as a treatment for horses with reduced insulin sensitivity.
Publication Date: 2005-07-13 PubMed ID: 16008228DOI: 10.2460/ajvr.2005.66.1032Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Comparative Study
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research study examines the effect of levothyroxine sodium on glucose and lipid metabolism in healthy adult horses. It found that administration of this compound reduced blood lipid concentrations, improved insulin sensitivity, and increased insulin disposal, suggesting its potential as a treatment for horses with reduced insulin sensitivity.

Methodology of the Research

  • In the study, 12 healthy adult mares were used as the subjects. Eight of these horses were given an incrementally increasing dosage of levothyroxine sodium (24, 48, 72, or 96 mg per day) for 8 weeks.
  • The medication was given between 7 AM and 8 AM in their morning grain meal for 2 weeks. The other four horses were not given any treatment and served as controls.
  • The researchers measured levels of various parameters such as nonesterified fatty acids, triglyceride, total cholesterol, and very-low-density lipoprotein in blood samples taken between 8 AM and 9 AM at weeks 0, 2, 4, 6, and 8.
  • A combined Intravenous Glucose-Insulin Tolerance Test (IVGITT) was performed before and at the end of the treatment period to assess the horses’ glucose dynamics. This data was then interpreted using a minimal model.

Results of the Study

  • The results showed that the plasma concentrations of triglyceride, total cholesterol, and very-low-density lipoprotein significantly decreased over time in horses who received the levothyroxine sodium treatment. The mean plasma concentration of very-low-density lipoprotein decreased by more than half from the baseline value at the end of the treatment period.
  • Insulin sensitivity of the treated horses significantly improved, being more than two times greater than the initial value. This means that the horses became more efficient at regulating their blood sugar levels after the treatment. However, the glucose effectiveness and net insulin response were not affected.
  • The rate of insulin disposal, which is how quickly insulin is removed from the body, significantly increased.

Conclusions of the Research

  • Based on these outcomes, the study concluded that the administration of levothyroxine sodium decreases blood lipid concentrations, improves insulin sensitivity, and increases the rate of insulin disposal in horses.
  • This suggests that levothyroxine sodium can potentially be used as a treatment for horses with decreased insulin sensitivity. However, further studies are required to strengthen this hypothesis and describe the exact mechanisms involved.

Cite This Article

APA
Frank N, Sommardahl CS, Eiler H, Webb LL, Denhart JW, Boston RC. (2005). Effects of oral administration of levothyroxine sodium on concentrations of plasma lipids, concentration and composition of very-low-density lipoproteins, and glucose dynamics in healthy adult mares. Am J Vet Res, 66(6), 1032-1038. https://doi.org/10.2460/ajvr.2005.66.1032

Publication

ISSN: 0002-9645
NlmUniqueID: 0375011
Country: United States
Language: English
Volume: 66
Issue: 6
Pages: 1032-1038

Researcher Affiliations

Frank, Nicholas
  • Department of Large Animal Clinical Sciences, College of Veterinary Medicine, University of Tennessee, Knoxville, TN 37996, USA.
Sommardahl, Carla S
    Eiler, Hugo
      Webb, Latisha L
        Denhart, Joseph W
          Boston, Ray C

            MeSH Terms

            • Animals
            • Dose-Response Relationship, Drug
            • Female
            • Glucose / metabolism
            • Glucose Tolerance Test / veterinary
            • Horses / metabolism
            • Insulin / blood
            • Lipids / blood
            • Lipoproteins, VLDL / blood
            • Thyroxine / pharmacology
            • Time Factors

            Citations

            This article has been cited 7 times.
            1. Kim H, Jung DY, Lee SH, Cho JH, Yim HW, Kim HS. Retrospective cohort analysis comparing changes in blood glucose level and body composition according to changes in thyroid-stimulating hormone level. J Diabetes 2022 Sep;14(9):620-629.
              doi: 10.1111/1753-0407.13315pubmed: 36114679google scholar: lookup
            2. Daradics Z, Crecan CM, Rus MA, Morar IA, Mircean MV, Cătoi AF, Cecan AD, Cătoi C. Obesity-Related Metabolic Dysfunction in Dairy Cows and Horses: Comparison to Human Metabolic Syndrome. Life (Basel) 2021 Dec 16;11(12).
              doi: 10.3390/life11121406pubmed: 34947937google scholar: lookup
            3. Durham AE, Frank N, McGowan CM, Menzies-Gow NJ, Roelfsema E, Vervuert I, Feige K, Fey K. ECEIM consensus statement on equine metabolic syndrome. J Vet Intern Med 2019 Mar;33(2):335-349.
              doi: 10.1111/jvim.15423pubmed: 30724412google scholar: lookup
            4. Seddighi R, Doherty TJ. Anesthesia of the geriatric equine. Vet Med (Auckl) 2012;3:53-64.
              doi: 10.2147/VMRR.S34162pubmed: 30101084google scholar: lookup
            5. Morgan R, Keen J, McGowan C. Equine metabolic syndrome. Vet Rec 2015 Aug 15;177(7):173-9.
              doi: 10.1136/vr.103226pubmed: 26273009google scholar: lookup
            6. Lacombe VA. Expression and regulation of facilitative glucose transporters in equine insulin-sensitive tissue: from physiology to pathology. ISRN Vet Sci 2014;2014:409547.
              doi: 10.1155/2014/409547pubmed: 24977043google scholar: lookup
            7. Anger-Håål C, Fjordbakk CT, Ekstrand C, Skedsmo FS, Rørtveit R. Sodium-glucose transporters SGLT1 and SGLT2 in equine renal, hepatic and pancreatic tissue. BMC Vet Res 2025 Dec 17;22(1):36.
              doi: 10.1186/s12917-025-05173-1pubmed: 41408266google scholar: lookup